Role of amniotic fluid homocysteine level and of fetal 5,10- methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects

American Journal of Medical Genetics

Volumn 90, Issue 1, 2000, Pages 12-16

  Wenstrom, Katharine D ^a   Johanning, Gary L ^a   Owen, John ^a   Johnston, Kelley E ^a   Acton, Shannon ^a   Tamura, T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Homocysteine; MTHFR genotype; Neural tube defects

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; FETUS; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; AMINO ACID SUBSTITUTION; AMNIOTIC FLUID; FEMALE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; OXIDOREDUCTASES; POINT MUTATION; PREGNANCY; VALINE;

EID: 0033988240     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000103)90:1<12::AID-AJMG3>3.0.CO;2-H     Document Type: Article

References (23)

1. Bjorke-Monsen AL, Ueland PM, Schneede J, Vollset SE, Refsum H. 1997. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. Q J Med 90:593-596.
2. Czeizel AE, Dudäs I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
3. Frosst P, Blom HJ, Milos I. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
4. Hibbard BM. 1964. The role of folic acid in pregnancy - with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Brit Commw 71:529-542.
5. Hibbard ED, Smithells RW. 1965. Folic acid metabolism and human embryopathy. Lancet i:1254.
6. Kurczynski TW, Muir WA, Fleisher LD, Palomaki JF, Gaull GE, Rassin DK, Abramowsky C. 1980. Maternal homocysteinuria: studies of an untreated mother and fetus. Arch Dis Child 55:721-723.
7. Lucock MD, Wild J, Lumb CH, Oliver M, Kendall R, Daskalakis I, Schorah CJ, Levene MI. 1997. Risk of neural tube defect-affected pregnancy is associated with a block in maternal one-carbon metabolism at the level of N-5 methylenetetrahydrofolate: homocysteine methyltransferase. Biochem Mol Med 61:28-40.
8. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
9. Milunsky A. 1992. Maternal serum screening for neural tube and other defects. Milunsky A, Ed. In: Genetic disorders and the fetus. Diagnosis, prevention, and treatment, 3rd ed. Baltimore: The Johns Hopkins University Press. p 507-511.
10. Motulsky AG. 1996. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 119;58:17-20.
11. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
12. Ou CY, Stevenson RE, Brown VK, et al. 1996. 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
13. Steegers-Theunissen RPM, Steegers EAP, Boer R, Thomas CMG, Kloosterman MD, Eskes TKAB. 1990. Elevated folate levels in amniotic fluid after oral supplementation. Eur J Obstet Gynaecol 36:283-298.
14. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CM, Borm GF, Wouters MG, Estes TK. 1994. Maternal hyperhomocysteinaemia: A risk factor for neural tube defects? Metabolism 43:1475-1480.
15. Steegers-Theunissen RPM, Boers GH, Blom HJ, Nijhuis JG, Thomas CM, Borm GF, Estes TK. 1995. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172:1436-1441.
16. Steegers-Theunissen RPM, Wathen NC, Eskes TKAB, van Raaij-Selten B, Chard T. 1997. Maternal and fetal levels of methionine and homocysteine in early human pregnancy. Br J Obstet Gynecol 104:20-24.
17. Tamura T, Johnston KE, Bergman SM. 1996. Homocysteine and folate concentrations in blood from patients treated with hemodialysis. J Am Soc Nephrol 7:2414-2418.
18. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. 1993. Total homocysteine in plasma or serum: methods and clinical applications. Clinical Chemistry 39:1764-1779.
19. van Aerts LAGJM, Blom HJ, de Abreu RA, Trijbels FJ, Eskes TK, Copius Peereboom-Stegeman JH, Noordhoek J. 1994. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured post-implantation embryos. Teratology 50:348-360.
20. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FG, Estes TK, van den Heuvel LP, Mariman EC. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
21. van der Put NMJ, van der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels JM, Estes TK, van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ. 1997. Sequence analysis of the coding region of human methionine synthase: relevance to hyper homocysteinemia in neural tube defects and vascular disease. Q J Med 90:505-510.
22. van der Put NJM, Eskes TKAB, Blom HJ. 1997. Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Q J Med 90:111-115.
23. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. 1995. A genetic defect in 5,10-methylenetetrahydrafolate reductase in neural tube defects. Q J Med 88:763-766.